As retatrutide is not yet approved in the UK, any product currently being marketed or sold as retatrutide outside of a regulated clinical trial has not been assessed for safety or quality by the Medicines and Healthcare products Regulatory Agency (MHRA), and its use carries significant risk
[1] If during injection a patient experiences chest pain, difficulty breathing, hives, or swelling of the face or throat, it could indicate anaphylactic shock
J Clin Oncol 28:44854491 Wilson P, Anastasaki A, Owen MR, Kempe K, Haddleton DM, Mann SK, Johnston AP, Quinn JF, Whittaker MR et al (2015) Organic arsenicals as efficient and highly specific linkers for protein/peptidepolymer conjugation
When taking medications like semaglutide, bloating can result from changes in how your body digests food